Mountain Crest Acquisition Corp. V (MCAG) Signs Term Sheet with CUBEBIO for $620M Deal

Mountain Crest Acquisition Corp. V (MCAG) Signs Term Sheet with CUBEBIO for $620M Deal

Mountain Crest V (NASDAQ:MCAG) broke a long dealmaking silence by SPACs this morning, albeit with a non-binding agreement to combine with Seoul-based diagnostic biotech firm CUBEBIO. The term sheet would give the company a $620 million pre-transaction equity value and help accelerate the rollout of CUBEBIO’s CEED-NOVUS cancer screening kit products. The company signed an
Read More

To access this post, you must purchase 1 - User: Monthly Plan.